← All organizations
Highest phase reached
Phase 1
First clinical trial
May 3, 2013Last known activity
Jan 1, 2015
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 2 trials)
Indications
Studied for
- Hodgkin Disease
- Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lymphoma
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Syndrome
Recent trials (2)
- NCT02194374CollaboratorPhase 1Jan 1, 2015
- NCT01619761CollaboratorPhase 1May 3, 2013
Details
- Last known activity
- Jan 1, 2015